UTHR · Categories · Coverage

UTHR - Analyst coverage initiated

United Therapeutics Corporation (UTHR) analyst coverage initiated - real-time wire coverage filtered to Coverage only.

Recent Coverage for UTHR

• 73d
  Raymond James initiated coverage on United Therapeutics with a new price target

  Raymond James initiated coverage of United Therapeutics with a rating of Outperform and set a new price target of $700.00
• 245d
  Wells Fargo initiated coverage on United Therapeutics with a new price target

  Wells Fargo initiated coverage of United Therapeutics with a rating of Underweight and set a new price target of $414.00
• 269d
  RBC Capital Mkts initiated coverage on United Therapeutics with a new price target

  RBC Capital Mkts initiated coverage of United Therapeutics with a rating of Outperform and set a new price target of $569.00
• 385d
  Cantor Fitzgerald initiated coverage on United Therapeutics with a new price target

  Cantor Fitzgerald initiated coverage of United Therapeutics with a rating of Overweight and set a new price target of $405.00
• 868d
  Leerink Partners initiated coverage on United Therapeutics with a new price target

  Leerink Partners initiated coverage of United Therapeutics with a rating of Outperform and set a new price target of $330.00
• 927d
  Wells Fargo initiated coverage on United Therapeutics with a new price target

  Wells Fargo initiated coverage of United Therapeutics with a rating of Overweight and set a new price target of $309.00
• 1294d
  UBS initiated coverage on United Therapeutics with a new price target

  UBS initiated coverage of United Therapeutics with a rating of Buy and set a new price target of $320.00
• 1295d
  Goldman initiated coverage on United Therapeutics with a new price target

  Goldman initiated coverage of United Therapeutics with a rating of Sell and set a new price target of $230.00
• 1350d
  Morgan Stanley initiated coverage on United Therapeutics with a new price target

  Morgan Stanley initiated coverage of United Therapeutics with a rating of Overweight and set a new price target of $288.00
• 1592d
  BTIG Research initiated coverage on United Therapeutics

  BTIG Research initiated coverage of United Therapeutics with a rating of Neutral

Other UTHR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings